Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Alfred Witjes

Showing results (11-20 of 378) with videos related to

Pageof 38
Sort By:
World Journal of Urology|December 28, 2020
Follow-up in non-muscle invasive bladder cancer: facts and futureJ Alfred Witjes
European Urology|February 17, 2021
Re: Five-factor Prognostic Model for Survival of Post-platinum Patients with Metastatic Urothelial Carcinoma Receiving PD-L1 InhibitorsJ Alfred Witjes
Current Opinion in Urology|March 7, 2020
Developments in the follow-up of nonmuscle invasive bladder cancer: what did we learn in the last 24 months: a critical reviewJ Alfred Witjes
European Urology|March 2, 2019
Re: Bladder Preservation with Twice-a-day Radiation plus Fluorouracil/Cisplatin or Once Daily Radiation plus Gemcitabine for Muscle-invasive Bladder Cancer: NRG/RTOG 0712-A Randomized Phase II TrialJ Alfred Witjes
European Urology|July 28, 2009
Editorial comment on: Clinical outcome in a contemporary series of restaged patients with clinical T1 bladder cancerJ Alfred Witjes
European Urology|November 27, 2012
Maintenance bacillus Calmette-Guérin for non-muscle-invasive bladder cancer: do we finally know the best schedule?J Alfred Witjes
European Urology|June 16, 2016
Re: Trends in the Use of Perioperative Chemotherapy for Localized and Locally Advanced Muscle-invasive Bladder Cancer: A Sign of Changing TidesJ Alfred Witjes
Nature Reviews. Urology|June 19, 2013
Bladder cancer: Elderly and female patients fare the worst and deserve betterJ Alfred Witjes
European Urology|June 29, 2013
A case of abiraterone acetate withdrawalJ Alfred Witjes
Urology|December 8, 2009
Editorial commentJ Alfred Witjes
Pageof 38

Showing results (11-20 of 378) with videos related to

Sort By:
Pageof 38
World Journal of Urology|December 28, 2020
Follow-up in non-muscle invasive bladder cancer: facts and futureJ Alfred Witjes
European Urology|February 17, 2021
Re: Five-factor Prognostic Model for Survival of Post-platinum Patients with Metastatic Urothelial Carcinoma Receiving PD-L1 InhibitorsJ Alfred Witjes
Current Opinion in Urology|March 7, 2020
Developments in the follow-up of nonmuscle invasive bladder cancer: what did we learn in the last 24 months: a critical reviewJ Alfred Witjes
European Urology|March 2, 2019
Re: Bladder Preservation with Twice-a-day Radiation plus Fluorouracil/Cisplatin or Once Daily Radiation plus Gemcitabine for Muscle-invasive Bladder Cancer: NRG/RTOG 0712-A Randomized Phase II TrialJ Alfred Witjes
European Urology|July 28, 2009
Editorial comment on: Clinical outcome in a contemporary series of restaged patients with clinical T1 bladder cancerJ Alfred Witjes
European Urology|November 27, 2012
Maintenance bacillus Calmette-Guérin for non-muscle-invasive bladder cancer: do we finally know the best schedule?J Alfred Witjes
European Urology|June 16, 2016
Re: Trends in the Use of Perioperative Chemotherapy for Localized and Locally Advanced Muscle-invasive Bladder Cancer: A Sign of Changing TidesJ Alfred Witjes
Nature Reviews. Urology|June 19, 2013
Bladder cancer: Elderly and female patients fare the worst and deserve betterJ Alfred Witjes
European Urology|June 29, 2013
A case of abiraterone acetate withdrawalJ Alfred Witjes
Urology|December 8, 2009
Editorial commentJ Alfred Witjes
Pageof 38